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INTRODUCTION
Doctor C. P. Rhoads, speaking at Yale Medical
School this winter, ventured the opinion that current studies
of host reactions to tumors were providing some of the most
exciting leads in cancer research.

Work at Dr. Rhoads’

Sloan-Kettering Institute has shown that transplantation of
cancer into people afflicted with terminal carcinomatosis will
yield rapid and progressive growth of the implant while the
same cancer transplanted into normal people will evoke an
inflammatory response and subsequent death of the transplant.
This demonstration of the altered reactivity of the person
harboring a malignant growth points up the need to study the
tumor host, his defenses and how they may be altered.

The

emphasis on the study of the host as well as the tumor has
gained increasing recognition in the field of animal cancer
research over the last decade.
THE ENCHANCING EFFECT
Woglom’s review article, ’’Immunity to Transplant¬
able Tumors”, published in 1929 stressed the natural defenses
to transplantation of tumors and the increased immunity to
tumors following previous injection of that tumor (57).
However, as early as 190? Flexner and Jobling had found that
rats injected with a heated emulsion of rat sarcoma ten days
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prior to the injection of a live graft of this tumor had a
greater number of growths and the tumors showed more rapid
growth as compared to animals who had not received the heated
emulsion (17).
effect.

Unheated emulsion failed to reproduce this

Here, then, was evidence that prior contact with a

tumor could decrease a rat’s immunity to subsequent contact
with the same tumor.
Casey (9,14) showed that prior injection of frozen
Brown-Pearce rabbit tumor into the testicle,

skin, subcutan¬

eous tissue or muscle of rabbits changed these animals so
that subsequent inoculations of live Brown-Pearce tumor gave
increased number of growths,

increased size of growths,

decreased survival time and increased mortality as compared
to animals which had not been pretreated.

Pretreatment with

fresh tumor did not elicit this phenomenon which Casey called
the XYZ effect.

The specificity of the XYZ effect was

demonstrated by the inability of pretreatment with frozen
Brown-Pearce tumor in mice to enhance the growth of Bashford
mouse carcinoma (10).

An even greater specificity of this

reaction was revealed when Casey (11)

showed that mouse

sarcoma ISO, anaerobically refrigerated for 14 to 60 days at
24° Fahrenheit, then minced,

emulsified and used for pre¬

treatment in mice enhanced the growth of grafts of live Sarcoma
ISO but had no effect on the growth of grafts of Sarcoma 63
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or Sarcoma 37.

Material prepared from a uterine adenocarcin¬

oma of rabbits did not enhance the growth of Brown-Pearce
tumor (13).

Furthermore, injection of 0.3 cubic centimeters

of a filtrate of fresh Brown-Pearce tumor that had been passed
through a Berkefeld V filter inhibited the growth of subsequent
grafts of Brown-Pearce tumor (12).
Snell, Kaliss and their co-workers have studied
intensively the effects of pretreatment of animals with
lyophilized tissue, both normal and malignant.

This pretreat¬

ment could enhance or inhibit the growth of subsequent live
tumor transplants and which of the two predominated seemed,
in large measure, to be determined by specific host straintumor relationship (49).

Tumor 15091A, which grows in

Strain A mice but not in Strains C57 or Balb C, when given as
lyophilized pretreatment to the latter two strains induced an
increase number of takes of subsequent grafts of live 15091A
tumor.

Lyophilized myeloid leukemia C149& used as pretreat¬

ment in C57 leaden and C57 black strain mice caused a 50 per
cent reduction in the number of takes of subsequent live
C149S grafts (43).

Swiss white mice treated with frozen

Sarcoma 1&0 then injected with viable tumor showed a decreased
number of takes compared to animals that had not been pretreated
(53).

Kaliss and Snell (23) studied the growth of tumor

15091A in C57 black and C57 brown mice following pretreatment
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with lyophilized normal tissue from Strain A mice, lyophilized
tumor 15091A and lyophilized kidney from Strains C and P.

The

results are summarized below:

Pretreatment
tissue

No. animals showing
progressive growth
Brown
Black

Strain A
1. liver
2. kidney
3. spleen
4. red cells

8/31
13/30
9/14
0/24

2/10
6/10
9/10

Tumor 15091A

28/35

5/9

Strain C
1. kidney

l/l8

-

Strain P
1. kidney

0/22

-

Controls

0/33

0/10

It was evident that lyophilized normal tissue from
the natural host of the tumor could alter the resistence of
a foreign strain to live grafts of that tumor (26).

Kaliss

(24) demonstrated that fresh tumor sediment could act to
enhance tumor grafts.

The enhancing effect of live tumor in

Kaliss’ system contrasts with the previously noted failure of
Flexner and Jobling (17) to demonstrate an enhancing effect
with live tumor.
The failure of non specific substances to produce
the enhancing effect was shown by the inability of trypan
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blue and lyophilized kidney, liver and spleen of the rat,
hamster and guinea pig to enhance the growth of 15091A tumor
in C57’s (25,27).

Other work, though, showed that normal

kidney and spleen of C57 B1 mice used as lyophilized pretreat
ment in rats could enhance the take of a mouse mammary car¬
cinoma in the rats although the mouse mammary carcinoma does
not grow in the C57 Bl’s (47).

This suggestion of a species

specificity is at odds with Casey’s work with mouse sarcoma
and the report of Kaliss and Snell, previously cited, that
kidney from Strains C and P did not enhance the growth of
tumor 15091A.

This again points up the danger of generalizing

beyond the specific host-tumor system being studied.
The use of cortisone with the pretreatment has
been reported by Kaliss (33,36).

Cortisone did not increase

the number of takes and there is some suggestion that corti¬
sone inhibits tumor graft growth when given in this manner.
The factors of age at onset of pretreatment and
time interval between pretreatment and transplantation of
live tissue has been studied.

Kaliss found that pretreatment

had to start before the live graft was made or, at the very
latest, the day after the live transplantation (37).

The

effect of pretreatment is evident ten months after its con¬
clusion in the mouse (32).

Pikovski and Schlesinger (47)

showed that the most important temporal factor was the age
of the animal at the time pretreatment was begun.

Animals
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below ten days of age when pretreatment was begun gave con¬
sistently the highest number of takes.

The time interval

between pretreatment and the live grafting assumes much
greater importance when live tissue rather than lyophilized
tissue is used as pretreatment.

If the time interval between

two subcutaneous inoculations of Sarcoma I in C57B1 mice was
greater than one month the second graft took while if the
interval was less than one month the second graft regressed.
None of the initial grafts grew (35).
The amount of lyophilized tumor used in the pre¬
treatment is one determinate of whether the pretreatment will
yield enhancement or inhibition.

Mammary adenocarcinoma

Eo771 injected into C3H Jax mice will produce a mortality
rate of 50 per cent.

Use of 50 milligrams of lyophilized

Eo771 as pretreatment will greatly increase this mortality
rate while use of .05 milligrams for pretreatment will decrease
the mortality rate almost to zero.

Dosages in between pro¬

duce gradations of mortality which are directly proportional
to the dose (22}30),
The use of specific antisera to transmit the
enhancing effect has been elucidated by Kaliss and Molomut.
In one study C57Bl/6Ks mice were injected with splenic tissue
from Strain A mice and the serum from these C57fs was injected
into normal C57Bl/6Ks mice.

The latter mice then received
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transplants of Sarcoma I which is indigenous to Strain A.
Six of fifteen animals so treated died while fifteen normal
C57’s received the grafting with no mortality (31).

The

same effect can be produced by antisera to Strain A kidney
and to tumor 15091A which grows in Strain A (2$).

The per

cent of animals with actively growing tumors after this
method of pretreatment is much lower than that usually
obtained after pretreatment with lyophilized tumor (2&).
The growth of tumors in resistant animals follow¬
ing pretreatment of the animals produces a change in the
tumor, as evidenced by an ability to grow in other normally
resistent strains which have not been pretreated (34).

A

tumor from an inbred strain will gro*w in all mice of the
same strain and FI hybrids having that strain as one parent.
Resistant backcross animals (FI hybrids x resistant animal)
have takes of between 30 per cent to .002 per cent with the
tendency toward the lower figures.

A tumor that grows in

C3H's but not in C mice will, after growth in FI’s of these
two strains, when transplanted into resistant backcross mice
yield three and one half times (30 per cent vs. eight per cent)
greater mortality than those tumors received directly from
C3H animals (2,4).

This change in the tumor is permanent and

can be repeatedly demonstrated after one passage through the
resistant backcross,

(3).

An indication that the change in host resistence
following pre-treatment with lyophilized tissue has greater
applicability than the host-tumor systems usually studied was
revealed by an increased number of survivals of transplanted
embryonic tissue and normal spleen in pretreated mice (29).
Snell (50) viewing the whole field of transplanta¬
tion cited the factor of common ancestry as favoring the
growth of homiotransplants (homiotransplants being defined
as transplants from one inbred strain to another inbred strain).
His study of the genetic pattern of transplantation pinpointed
a ’’histocompatability gene” (H-2 allele) as being the deter¬
minate of the success or failure of a transplant (50).
The enhancing effect is basically immunological
with the characteristics of (a) specificity,
(c) ability to be passively transferred,

(b) persistency,

(d) necessity for

pretreatment injections to be made before the period of
active transplant growth (51).
The nature of the enhancing material in Sarcoma I
from Strain A mice was delineated by Day, Kaliss and their
co-workers (16).

The enhancing factor was,

able and water soluble,

(a) water extract-

(b) unstable above 60° centigrade,

(c) destroyed by prolonged autolysis or by acid and alkaline
hydrolysis,

(d) either a part of or associated with a

denaturable high molecular weight protein,

(e) in tissues it
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appears to be a constituent of cellular particulates and
presumably available only in small amounts as a circulating
humoral factor,
ACTIVELY ACQUIRED TOLERANCE
Burnet and Fenner, in their book,

,fThe Production

of Antibodies”, postulated that antibody production against
a particular antigen can be specifically suppressed by
exposure to the same antigen during embryonic life.
Such an exposure occurs in bovine twin embryos
because of vascular anastomoses which allow admixture of the
bloods of the twins (45).

As adults these animals do not

form antibodies to the blood cells of their twin.

Experi¬

mentally producing an anastomosis between allantochorionic
vessels of two chicks and then after birth challenging these
chicks with their partner’s erythrocytes reveals that these
chicks do not form isoagglutins to the erythrocytes (19).
Burnet et.al.

(8) inoculated chick embryos with

1) influenza, 2) bacterial viruses, and 3) human red cells
in an attempt to prove experimentally their postulate.

How¬

ever, these animals as adults did not differ from control
animals in their response to the three antigens.
In a classic work Billingham, Brent and Medawar
(5) injected six 15 to 16 day old mouse embryos in utero with
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a ,01 milliliter suspension of tissue from the testes,
ney and spleen of adult A line male mice.

kid¬

The embryos were

all part of one pregnancy of a CBA female.

The injections

were done at laparotomy and after the injections were com¬
pleted the incision was closed and the pregnancy allowed to
go to term.

At that time five animals were born,

being no trace of the sixth.

there

At age eight weeks the five

animals were grafted with adult A line skin.

Eleven days

later two of these grafts were in an advanced stage of break¬
down but the other three resembled autografts except for the
strain specific albinism.

Two of these three grafts were

completely viable at the end of two months.

That this was a

specific reaction to A line skin was demonstrated when skin
from another line was grafted to the animals with a resultant
complete breakdown of this latter graft.

The hosts ability

to react to A line tissue had been altered but its reactivity
to other antigens had not been altered.

The initial grafts

broke down when the hosts were inoculated with chopped lymph
nodes from normal CBA’s or from CBA’s which had been immunized
to A line skin (5,6),

This proves that the antigenicity of

the graft had not been impaired but rather that its take was
dependent on changes in the host’s resistence.

The litters

of these animals did not show any increased tolerance to A
line skin (5).

11
At the sixteenth to seventeenth day of gestation
ICR mouse embryos were injected with either (a)
C3H mice or
(c)

(b)

blood of

blood of FI mice from C3H x DBA matings or

suspension of lymphosarcoma 6C3 which is lethel to C3H

mice but does not grow in ICR mice.

Six to eight weeks

following birth the animals that had received the blood
injections in utero were given intraperitoneal injections of
6C3HED which yielded an ascites tumor in all the animals
(37).

The

embryos which received tumor cells had palpable

tumors ten to 25 days after birth.

These embryos were

incapable of rejecting the tumor which is universally resisted
by adult mice of the same

strain.

A suspension of the tumor

grown in the embryonic mice injected into strains normally
resistent to this tumor enjoyed a growth comparable to that
in the indigenous strain.

This loss of host specificity is

similar to that previously noted by Barrett and Deringer (2).
Koprowski

(3$),

elaborating on his earlier work,

injected DBA mouselymphoma into ICR mouse embryos.

This tumor

I

i

does not grow in adult ICR mice but in this study takes of
75 to 100 per cent were reported in the embryos.

This is

another example of the embryos inability to produce resistence
to a foreign antigen.
Wallace

(56) was unable to produce tolerance to

tumors when he injected rat embryos with tissue

from the
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strain that the tumor normally grows in.
were made on the

His injections

sixteenth day of gestation,

used were normal cells of spleen,

liver,

suspended in a balanced salt solution.

and the tissues

kidney and testes
The following

summarizes Wallace’s results:

Tumor

Recipient

Antigen_

No. with growth
to death of host
Control

1.C3HBA
2,Sarcoma ISO
(from C3H mice)
3.dbrB
(from DBA mice)
4.35FM (from SpragueDawley rats)
5.53FM (from SpragueDawley rats)
6.53FM (from SpragueDawley rats)

Wallace

Test

Wistar

C3H cells

0/10

0/20

Wistar

C3H cells

0/9

0/21

Wistar
Hooded

DBA cells
SpragueDawley cells
SpragueDawley cells
SpragueDawley cells

0/17

0/16

0/15

0/17

0/15

0/7

0/20

4/18

Hooded
Wistar

suggests that the use of the

same tumor

for treatment of the embryos and for the adult graft might
have produced better results.

Billingham et.

al„,

though,

achieved their success through the use of normal tissue for
pretreatment.

Here again the difference my lie in a species

specificity or a specificity within a species.

The latter

is suggested by Wallace’s limited success with one hosttumor system (53FM tumor-Wistar rats),
Toolan (55) was also unsuccessful when she tried
to produce tolerance in rats to human tumors by in utero
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injections.

Her pretreatment material was normal human

tissue which was obtained from persons other than those who
yielded the carcinoma.

This difference in the antigen and

the tumor may,

explain the failure.

in part,

Felton

(16)

found that injection of 0,5 milligrams

of soluble polysaccharide into C3H mice paralyzed the
animals ability to produce antibody to injected pneumococci.
The susceptibility of the mouse embryo to treat¬
ment with foreign antigen as shown by Billingham et. al,
raises the question of whether the embryo can be treated
by ways other than direct injection.

The transmission from

mother to fetus of passive immunity to certain diseases has
long been recognized.

This illustration of the passage of

antibodies through the placenta has been supplemented by
work showing that many drugs pass from mother to child in
utero,

e.g.

barbiturates,

narcotics

(18).

Studies of

erythroblastosis fetalis gave rise to the belief that fetal
red cells pass into the maternal circulation and thus stim¬
ulate antibody formation (39).

This transplacental transfer

of red cells was believed to be on a limited scale and due
to imperfections of the placenta peculiar to this disease.
That this admixture of blood cells occurs in normal preg¬
nancies and through normal placentas was conclusively demon¬
strated by Mengert and his group (41).

They injected normal

pregnant women with sickle cells and at birth recovered
these sickle cells from cord blood.
In this study it was hoped that by injecting preg¬
nant mice with a subcutaneous tumor a change in the reactivity
of the embryos to that tumor could be elicited.
be accomplished in one of two ways.

Firstly,

from the mother might pass to the embryo.

This could

tumor cells

If red cells can

pass through a human placenta it is not too unreasonable to
hope that tumor cells could pass through
mouse placenta.

the less complex

Secondly, the formation by the mother of
/1

specific antiserumto the tumor with subsequent transmission
to the fetus of that antiserum might
the tumor in the fetus.

enhance the growth of

The use of such antisera to enhance

tumor growth has previously been cited in the discussion of
the work of Kaliss and Molomut

(2$),

Or, more directly,

enhancing factor itself might be transmitted through the
placenta.

METHODS AND MATERIALS

This study was divided into two parts.

PART ONE

Pregnant mice of Line CB2~j were inoculated sub¬
cutaneously in the axillary region with live mouse fibro¬
sarcoma 397.

This tumor does not grow in CB-j mice.

The

animals in this experiment were two to four months old.

The

tumor was obtained from BC mice carrying the tumor which was
in its nineteenth to twentyfourth generation.
The offspring from these pregnancies received sub¬
cutaneously in the interscapular area inoculations of tumor
397 at age eight to nine days.

These animals were checked

for tumor growth four to five times weekly until they were
six weeks of age.

PART TWO

Pregnant animals of the BC-a,

BC-b,

BC-c and BC-f

lines were inoculated subcutaneously in the axillary region
with live mouse fibrosarcoma 397.

This tumor grows progress¬

ively in these strains producing very large ulcerating lesions
which do not metastasize but which kill 90 to 100 per cent
of the mice within four weeks.
were two to four months old.

The mice in this experiment
The tumor was obtained from BC

mice carrying the tumor which was in its 19-24 generation.
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The offspring from these pregnancies were inocu¬
lated subcutaneously in the interscapular area with tumor
397 within 24 hours of birth.

These animals were checked

for tumor growth four to five times per week.
were maintained on a prepared diet

All animals

(Purina Laboratory Chow)

and water ad libitum.
BC refers to a group of mice derived by hybridizing
PM females and C3H males and backcrosses to the PM mice
followed by brother-to-sister inbreeding.

Eleven sublines

were established and designated by lettering from a to k.
The mice used in the study have been inbred brother-to-sister
for more than 25 generations since the original hybridization.
CB2“j refers to hybrid mice derived by mating BC-j
females with C57 males.
Fibrosarcoma 397 is a tumor that arose in a BC30
female

(30 here refers to the number of generations of inbreed¬

ing) which starting at age 72 days had received 1.25 milli¬
gram weekly of testosterone proprionate.

Between day 72 and

7$ this animal also received x-radiation in three exposures
of 154r each on alternate days.

At death at age 615 days

this animal had a large sarcoma at the injection site cover¬
ing 2x3 centimeters of the lower back.

There was a 14x11

millimeter tumor growth in the liver and numerous smaller
implants in this organ.

The kidneys and spleen were normal.

The adrenals were large and spotted.

Left ovary was 2x3
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millimeter and there was a possibility that it contained
tumor.

The right ovary was very small.

well developed.

The uterus was

The pituitary was normal.

This tumor which originated in January of 1956 has
been maintained by passage in BC sublines a,
now (April 1957)
serial transfer.
and j.

is

b,

c,

d,

f and

in its twenty seventh generation of

The tumor does not grow in BC sublines g

Subcutaneous inoculation of the tumor into susceptible

animals yields large ulcerating lesions without metastases
which kill 90 to 100 per cent of the animals within three to
four weeks.
In another aspect of this study tissue from human
uterine myomata was transplanted into the anterior chamber
of the eyes of mice and guinea pigs

(20,42).

These animals

had been inoculated subcutaneously with pellets containing
diethylstilbestrol
(40).

(25 per cent)

and cholesterol

The tissue was obtained at laparotomy and,

(75 per cent)
through the

cooperation of the surgeons, was removed before the blood
supply of the uterus was compromised.
One group of mice received injections of .25 milli¬
grams of prednisolone every other day for a period of two
weeks starting on the day before transplantation.

This was

in addition to the pellets of diethylstilbestrol-cholesterol.

OBSERVATIONS
The inoculation of tumor into susceptible BC animals
within the first 24 hours after birth provoked an extreme
degree of cannibalism by the mothers.

It is conservatively

estimated that over 100 animals were lost to follow up
because of this infanticide.

Most of the cannibalism occurred

within 24 hours of the inoculation but the survivors of this
period were jeopordized again between ten and twelve days of
age.

Only three animals with tumors survived past day 13.

Therefore, it was apparent that the growth of the tumors had
to be ascertained at day ten in order to obtain any sort of
sample.
All of the BC mothers with tumors bore large
ulcerating lesions which killed them in three to four weeks.
There was no evidence of metastases.
All matings in the study of BC animals were between
litter mates.
The tissue from the human uterine myomata was
obtained from three different patients, all of whom were
undergoing total abdominal hysterectomy.

Though grossly the

transplants appeared to become vascularized after six or seven
days in the mice and guinea pigs, histological section of the
tissue between day 12 to 21 revealed only necrotic tissue
suggestive of muscle, or fibrous tissue hyperplasia.

The
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latter was interpreted as arising from the host animal in
response to the foreign body.

In the group of mice receiv¬

ing cortisone the eyes rapidly became infected and eventually
became abscesses.

There was no trace of the transplants in

these animals after three weeks.

RESULTS

TABLE 1
Growth of Tumor 397 in Mice Born to CB2-J Mothers
Carrying This Tumor

Mother

Day of Gestation
Mother Inoculated

Litter

Age at
Grafting

No, with
Tumor/Litter

CB2-j
135BC3S

16

Males:
1 brown
1 black
Females:
5 black
1 white

9 days

o/s*

CBrj K
33BC3S

16

Males:
3 black
1 brown
Females:
1 black
1 brown
1 white

9 days

1/9

CBrj
135BC35

19

Males:
1 black
3 white
Females:
2 black
2 brown
1 white

3 days

0/9

CB2”3 a
33BC3S

No inoculation

Males:
3 black
Females:
3 black
1 white

9 days

0/7

CEU-j
133BC33

No inoculation

Males:
None
Females:
8 black

9 days

o/d

CBp-j
133BC35

No inoculation

Males:
2 black
Fernales:
1 black
1 brown
1 white

9 days

1/5

♦Three of these animals had subcutaneous abcesses measuring
between three and six millimeters in diameter which were
originally mistaken for tumefactions.
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TABLE II
Growth of Tumor 397 in Mice Born to BC Mothers
Carrying this Tumor

Mother

Day of Gestation
Mother Inoculated

No. in
Litter

Survivors
at 10 days

Size of
Tumors

BC37b
113BC36

17

a

3

5 mm
5 mm
4 mm

BC3&f
2BC37

16

9

2

6 mm
no growth

BC37c
61Bc36

13

10

1

5 mm

BC36b
147BC35

17

7

2

5 mm
4 mm

BC37d
52BC36

13

6

2

4 mm
no growth

BC36b
161BC35

Mother not
inoculated

£

2

5
4 mm

Bc3$b
74Bc37

Mother not
inoculated

a

1

5 mm

♦This animal survived to the age of 22 days at which time
his tumor covered most of the back and measured over 16
millimeters in length.
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There was no tumor growth in any of the CB2~j
mothers.

The BC mothers with tumor implants all had

progressive growth of their tumor and these animals were
dead within three to four weeks after implantation of the
tumor.
The one tumor that grew in an experimental mouse
of CB2-j parentage was in a black male.

This tumor was

densely adherent to the skin and was bilobar.

The animal

was sacrificed at the age of 22 days (13 days after tumor
implantation) at which time the two lobes of the tumor
measured five millimeters and three millimeters in diameter
respectively.

Autopsy failed to reveal any metastases.

A

white female control mouse of CB2-j parentage had a four
millimeter in diameter subcutaneous tumor when sacrificed at
22 days of age.

There were no metastases.

There is no statistical difference between the
rate of growth in the experimental and in the control BC
mice.

The data is summarized in Table II.

DISCUSSION
The failure to demonstrate an altered reactivity
to fibrosarcoma 397 in animals born to mothers who carried
this tumor subcutaneously may be explained in two parts,
each part related to one of the hypotheses upon which this
study was based.
The first hypothesis was that tumor cells from
the mother could pass through the placenta into the fetus.
Koprowski (3$) showed that tumors inoculated into embryos
would yield progressive growth.

However, in this study

susceptible BC embryos never showed evidence of metastatic
disease which makes it unlikely that maternal tumor cells
ever reached the fetus.

This possibility cannot be entirely

ruled out since it has been demonstrated that tumor cells
free in the peritoneal cavity of humans do not always give
rise to metastatic growths.
Fibrosarcoma 397 though a highly vascular tumor
does not usually metastasize.

In retrospect the choice of

this tumor for the study was an unfortunate one.

Even with

a metastasizing tumor the possibility of tumor cells reach¬
ing the placenta would be limited by mechanical factors (15).
Clinical reports of placental metastases are extremely rare

(1).
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The second hypothesis was that immune sera from
the mother would pass to the fetus and act as an enhancing
factor.

Another possibility was that enhancing factor

itself would pass to the fetus. This study would seem to
indicate that no such thing occurred.
Fibrosarcoma 397 may not produce an enhancing
factor in the host animals or in any host.
One early study suggested that live tumor did not
contain enhancing factor in useable form and that physical
alteration,

e.g,,

freezing, heating,

the enhancing factor

(17).

used in this study.

However,

used live tissue,
Kaliss

was necessary to elicit

No such physical alteration was
other studies have successfully

(35,26).

(35)

gave two subcutaneous inoculations of

live Sarcoma I to resistent C57Bl/6ks mice and found that
if the inoculations were separated by an interval of greater
than one month the grafts took while if the interval was
less than one month the

second grafts regressed.

the initial grafts in the study took.

None of

In all our own experi¬

ments the interval between inoculation of the mother and the
subsequent inoculation of the offspring was less than a
month,
The need in clinical medicine for a method of trans¬
planting tissue such as skin or an organ like the kidney has

25
led to many attempts at homotransplantation.

With the

exception of transplants between identical twins or into
agammaglobulinemic subjects these homotransplants have been
universally unsuccessful

(7,44).

The possibility that treat

ment of a pregnant woman could alter the response of her
offspring to foreign tissued or organs in such a way that
the tissued would grow in the offspring is an intriguing one
The failure of this

study to demonstrate such an effect in

mice with fibrosarcoma 397 should not discourage further
research along these lines.

CONCLUSION
There was no evidence that animals born to mothers
who had been inoculated with mouse fibrosarcoma 397 had an
altered reactivity to injection of that tumor.

SUMMARY

1.

The experimental work relating to the effect

of altered host resistance to transplants is reviewed under
the headings of ’’Enhancing Effect” and ’’Acquired Tolerance”.

2.

Pregnant animals of strains both resistant

and susceptible to mouse fibrosarcoma 397 were inoculated
with this tumor.

The offspring of these pregnant animals

were inoculated in the neonatal period with fibrosarcoma 397.

3.

There was no difference in the growth of the

tumor in these offspring as compared to the offspring of
mothers which had not been inoculated with the tumor.
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